WallStSmart
IMVT

Immunovant Inc

NASDAQ: IMVT · HEALTHCARE · BIOTECHNOLOGY

$26.95
-0.15% today

Updated 2026-04-29

Market cap
$5.49B
P/E ratio
P/S ratio
EPS (TTM)
$-2.67
Dividend yield
52W range
$13 – $30
Volume
1.4M

Immunovant Inc (IMVT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
+8.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+29.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.1%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-2.0%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-18$-0.54+26.1%$26.28$26.36+0.3%
2025-11-10$-0.73-2.8%$23.35$22.89-2.0%
2025-08-11$-0.71-1.4%$15.46$15.21-1.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.73$-0.54+26.1%
2025-09-30$-0.71$-0.73-2.8%
2025-06-30$-0.70$-0.71-1.4%
2025-03-31$-0.71$-0.64+10.1%$160000.00-89.3%
2024-12-31$-0.75$-0.76-1.0%
2024-09-30$-0.60$-0.74-23.3%
2024-06-30$-0.53$-0.60-13.2%
2024-03-31$-0.43$-0.52-20.9%$1.50M
2023-12-31$-0.43$-0.36+16.3%
2023-09-30$-0.47$-0.45+4.3%
2023-06-30$-0.45$-0.57-26.7%
2023-03-31$-0.43$-0.46-7.0%

Frequently asked questions

Has Immunovant Inc beaten earnings estimates?
Immunovant Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of +8.0% over the last 4 quarters.
How does IMVT stock react to earnings?
IMVT stock has moved an average of -1.1% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.